191 related articles for article (PubMed ID: 15640359)
1. A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites.
Martinelli A; Cheesman S; Hunt P; Culleton R; Raza A; Mackinnon M; Carter R
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):814-9. PubMed ID: 15640359
[TBL] [Abstract][Full Text] [Related]
2. A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I.
Cheesman S; O'Mahony E; Pattaradilokrat S; Degnan K; Knott S; Carter R
Int J Parasitol; 2010 Jul; 40(8):951-61. PubMed ID: 20153748
[TBL] [Abstract][Full Text] [Related]
3. Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria.
Pattaradilokrat S; Cheesman SJ; Carter R
PLoS One; 2007 Sep; 2(9):e857. PubMed ID: 17848988
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi.
Cheesman S; Tanabe K; Sawai H; O'Mahony E; Carter R
Infect Genet Evol; 2009 Mar; 9(2):248-55. PubMed ID: 19121414
[TBL] [Abstract][Full Text] [Related]
5. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.
Rainczuk A; Scorza T; Smooker PM; Spithill TW
Infect Immun; 2003 Aug; 71(8):4506-15. PubMed ID: 12874330
[TBL] [Abstract][Full Text] [Related]
6. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
7. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
8. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
Lynch MM; Cernetich-Ott A; Weidanz WP; Burns JM
Clin Vaccine Immunol; 2009 Mar; 16(3):293-302. PubMed ID: 19116303
[TBL] [Abstract][Full Text] [Related]
9. Synonymous and non-synonymous mutations in a region of the Plasmodium chabaudi genome and evidence for selection acting on a malaria vaccine candidate.
Black CG; Coppel RL
Mol Biochem Parasitol; 2000 Dec; 111(2):447-51. PubMed ID: 11163451
[No Abstract] [Full Text] [Related]
10. The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi.
Barclay VC; Sim D; Chan BH; Nell LA; Rabaa MA; Bell AS; Anders RF; Read AF
PLoS Biol; 2012; 10(7):e1001368. PubMed ID: 22870063
[TBL] [Abstract][Full Text] [Related]
11. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.
Scorza T; Grubb K; Smooker P; Rainczuk A; Proll D; Spithill TW
Infect Immun; 2005 May; 73(5):2974-85. PubMed ID: 15845504
[TBL] [Abstract][Full Text] [Related]
12. A single gene copy merozoite surface antigen and immune evasion?
O'Dea KP; McKean PG; Jarra W; Brown KN
Parasite Immunol; 1996 Apr; 18(4):165-72. PubMed ID: 9223171
[TBL] [Abstract][Full Text] [Related]
13. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes.
Crewther PE; Matthew ML; Flegg RH; Anders RF
Infect Immun; 1996 Aug; 64(8):3310-7. PubMed ID: 8757869
[TBL] [Abstract][Full Text] [Related]
14. Mixed allele malaria vaccines: host protection and within-host selection.
Barclay VC; Chan BH; Anders RF; Read AF
Vaccine; 2008 Nov; 26(48):6099-107. PubMed ID: 18804509
[TBL] [Abstract][Full Text] [Related]
15. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
Burns JM; Flaherty PR; Romero MM; Weidanz WP
Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
[TBL] [Abstract][Full Text] [Related]
16. Quantifying variation in the potential for antibody-mediated apparent competition among nine genotypes of the rodent malaria parasite Plasmodium chabaudi.
Fairlie-Clarke KJ; Allen JE; Read AF; Graham AL
Infect Genet Evol; 2013 Dec; 20():270-5. PubMed ID: 24056014
[TBL] [Abstract][Full Text] [Related]
17. Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice.
Cheesman S; Raza A; Carter R
Infect Immun; 2006 May; 74(5):2996-3001. PubMed ID: 16622238
[TBL] [Abstract][Full Text] [Related]
18. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
[TBL] [Abstract][Full Text] [Related]
19. Amplified fragment length polymorphism measures proportions of malaria parasites carrying specific alleles in complex genetic mixtures.
Martinelli A; Hunt P; Cheesman SJ; Carter R
Mol Biochem Parasitol; 2004 Aug; 136(2):117-22. PubMed ID: 15478791
[TBL] [Abstract][Full Text] [Related]
20. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
